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Elongator is an evolutionary highly conserved complex. At least two of its cellular functions rely on the intrinsic lysine acetyl-
transferase activity of the Elongator complex. Its two known substrates—Histone H3 and α-Tubulin—reﬂect the diﬀerent roles of
Elongator in the cytosol and the nucleus. A picture seems to emerge in which nuclear Elongator could regulate the transcriptional
elongationofa subsetofstress-inducible genes through acetylationofHistoneH3inthe promoter-distalgene body. In thecytosol,
Elongator-mediated acetylation of α-Tubulin contributes to intracellular traﬃcking and cell migration. Defects in both functions
of Elongator have been implicated in neurodegenerative disorders.
1.Introduction
Elongator was initially identiﬁed in yeast as part of the
RNA polymerase II (RNAPII) holoenzyme [1]. Since this
interaction was dependent on the hyperphosphorylation
of the C-terminal repeats of RNAPII, which is a mark of
transcriptional elongation, the complex was termed Elonga-
tor. The fully functional Elongator complex consists of six
subunits [2–4]and has a physiologically important role. This
is for instance demonstrated by several observations. First,
loss of Elongator function in yeast provokes hypersensitivity
to stresses including elevated temperature and osmotic con-
ditions[2, 5].Second,inArabidopsis, mutations in Elongator
result in growth defects [6]. Moreover, mice mutations in
Elongator subunits are embryonic lethal [7], and ﬁnally,
impaired Elongator activity has been correlated with familial
dysautonomia in human patients [8].
Both yeast and human Elongator have lysine acetyltrans-
ferase (KAT) activity [5, 9, 10]. Only two main substrates for
Elongator have been identiﬁed: Histone H3 and α-Tubulin.
These two diﬀerent substrates reﬂect the diﬀerent functions
of Elongator complex in the nucleus and in the cytosol.
After having been identiﬁed in the context of transcription,
it was ﬁrst surprising to ﬁnd that the major fraction of
the Elongator complex indeed resided in the cytosol [9–
12]. While in the nucleus acetylation of Histone H3 is
linked to the function of Elongator in transcription [13],
cytosolic acetylation of α-Tubulin by Elongator has been
recently connected to microtubules function particularly in
the context of cell migration [14].
Other functions of Elongator have also been described.
These include roles in tRNA processing [15, 16]a n d
exocytosis[17],whichhavebeenreviewedelsewhere[13,18].
Here, we will focus on the Elongator functions for which the
involvement of protein acetylation has been well established.
In particular, we will discuss similarities and diﬀerencesinits
molecular mode of function in the nucleus and cytosol. We
will further discuss the link between the dysfunction of the
Elongator complex and neurological disorders.
2.Biochemical and OtherAspectsofElongator
Elongator was ﬁrst copuriﬁed with yeast RNAPII as three
subunits containing complex [1]. Direct aﬃnity puriﬁ-
cations, however, made clear that the functional unit of
Elongator contains six subunits that can be separated in
two stable sub-complexes under high-salt conditions [2–4].2 Journal of Biomedicine and Biotechnology
The subunits of these two complexes were termed Elp1-
3 and Elp4-6. Although these proteins have been given
many other names depending on the contexts of their initial
identiﬁcation, for simpliﬁcation, here we will stick to the Elp
nomenclature.
All Elp proteins are evolutionary highly conserved which
is best illustrated by cross-species rescue experiments. Ara-
bidopsis Elp1 could rescue deﬁcient yeast [19], and human
Elp1 could rescue Elp1-deﬁcient neurons in mouse cortex
[7]. Human Elp3 and Elp4 could further compensate for the
lack of their counterparts in yeast [20].
Within the Elongator complex, the 150kDa protein Elp1
is the largest subunit. It contains several WD40 repeats
a n di sc o n s i d e r e dt om a i n l yf u n c t i o na ss c a ﬀold protein,
which is required for the formation of the complex [21].
More recently, however, Elp1 proteins from yeast, C. elegans,
and human were shown to possess RNA-dependent RNA
polymerase activity [22]. Elp2 also contains WD40 domain
[23]. In contrast to Elp1, however, Elp2 does not seem
to provide any scaﬀolding function since the remaining
complex could form in its absence [24]. The Elp3 subunit
of the complex possesses motifs characteristic of the GCN5
histone acetyl transferase family [5]a n dw a ss h o w nt ob e
able to acetylate histones [25]. In addition, Elp3 contains
an iron-sulfur cluster, which can bind S-adenosylmethionine
[26] and which is essential for the structural integrity of
the Elongator complex [27]. It was ﬁrst suggested that
this domain could have catalytic activity and function as
histone demethylase [28], but experimental studies failed to
conﬁrm this hypothesis. Instead, recent evidence suggests
that Elongator might be involved in DNA demethylation
[30]. The integrity of Elongator, and more particularly the
iron-sulfur cluster of Elp3, was shown to be essential for the
global zygoticDNAdemethylationoccurring onthe paternal
genome at the postfertilization stage [30]. On the basis of
sequence comparisons, it was suggested that Elp4 and Elp6
could be inactive orthologues of ancestral ATPases involved
in chromatin remodeling [31].
Combining geneticinactivation and aﬃnity puriﬁcations
[11, 21], Frohloﬀ and colleagues were the ﬁrst to putforward
a model for the architecture of the hexameric Elongator
complex that was largely conﬁrmed by others [32]. While
eﬀorts to determine the three-dimensional structure of the
Elongator complex are still under way, the model can serve
as a good basis for our experimental design. As shown in
Figure 1,Elp1isthecentralsubunitthatmediatesthebinding
of the two subcomplexes. On one side, Elp1 directly interacts
with Elp3, which in turn binds Elp2. On the other hand,
Elp1alsodirectlybindstheElp4-6subcomplexthroughElp4.
Whether Elp6 and Elp5 also directly contact Elp1 is less clear
at present.
The functional unit of Elongator is the holocomplex
containing all six subunits. This is best illustrated in yeast
where strains lacking any of the 6 Elp proteins have very
similar phenotypes. For instance, they display a particular
“slow start” phenotype as manifested by a pronounced delay
in adaptation to new growth medium [1, 4]. Elp-deﬁcient
strains are further temperature, salt, and caﬀeine sensitive
[2, 4] and resistant to the K. lactis killer toxin [3, 33]. There
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Figure 1: The Elongator complex and its components. (a)
Schematic view of the Elp proteins and their domain structure. (b)
Current model for the architecture of the Elongator complex.
is still some ambiguity in the questions whether elp-mutant
strains are sensitive to the pyrimidine analogue 6-azauracil
[1–3]. Most importantly, KAT activity of Elongator was
essential forthe rescue of all phenotypes in yeast. Removal of
almostanyoftheElongatorsubunitsaﬀectstheinteractionof
the others[11, 21,24, 32]and might explain why all subunits
are functionally essential in vivo. In line with this, it could
be demonstrated that Elongator requires all its subunits for
eﬃcient KAT activity [34].
Several proteins have been reported to interact with
components of the Elongator complex. These include Kti12
[33], IKB [35, 36], STAT3 [36], and PCNA [32]. Although
some interactions have been conﬁrmed in diﬀerent species,
most have only been found in a single species. It remains
to be seen which interactions are as conserved as Elongator
itself and which have evolved later. Mainly from studies
focusing on zymocin resistance in yeast, for instance, comes
the statement that Elongator interacts with the Hrr kinase
and the Sit4 phosphatase [37, 38]. In a series of publications,
the authors establish that these interactions result in cycles
of phosphorylation and dephosphorylation events that are
essential for Elongator function in zymocin resistance.
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relevant for the other functions of Elongator remains to
be elucidated. In addition, several interactions that have
been found by one group could so far not be conﬁrmed
by others, which suggests that many of these interactions
could be transient and might thus only occur under distinct
conditions. These “potential” interactors are not further
discussed here.
3.AcetylationofHistones:Elongatorin
Transcription
A surprising large number ofgenes, which can be inducedby
external stimuli, are regulated at the level of transcriptional
elongation [39, 40]. These genes include stress-inducible
genes as well as genes activated during developmental
processes. For these genes, RNAPII is stalled or paused in
c l o s ep r o x i m i t yt ot h ep r o m o t e r si nt h ea b s e n c eo ft h es t i m -
uli. Upon stimulation, the C-terminal domain of RNAPII
becomes hyperphosphorylated and resumes transcription
whose procession is controlled by elongation factors. These
elongation factors can be divided into active and passive
factors in respect to whether or not they directly aﬀect
enzymatic activity of RNAPII [41]. After several years of
controversy that followed the initial copuriﬁcation of the
Elongator with transcription-competent RNAPII [1], today
there is little doubt that one of the functions of Elongator is
indeed transcriptional elongat i o n .H o w e v e r ,t h ee x a c tm o d e
ofactionisstillnotfullyunderstood.Alsothedebatewhether
t h eE l o n g a t o rs h o u l db ec o n s i d e r e da sa c t i v eo rp a s s i v e
elongation factor is still open. Here, we review the data
of the last ten years that link Elongator to transcriptional
elongation.
The observationthat Elp3subunitis similar to theGCN5
suggestedearlythattheElongatorcomplexcouldbeahistone
acetyltransferase [5]. In vitro, puriﬁed Elp3 was able to
acetylate both H3 and H4 [5], and in vivo,am u t a n tl a c k i n g
itsputativeKATactivity had asimilar phenotypeas complete
loss of Elp3 [25, 33]. Synthetic lethality experiments further
provided the ﬁrst evidence pointing towards Histone H3
and in particular Lysine 14 as main in vivo target of Elp3
[25]. The functionality of Elongator’s KAT activity and its
speciﬁcity for Histone H3 were later conﬁrmed in several
species including yeast, plants, and mammalian cells [34,
42, 43]. In vitro, Elongator was able to enhance RNAPII
transcription from achromatinic template in an Acetyl-CoA-
dependent manner [10], while, on naked DNA, Elongator
had no inﬂuence on RNAPII transcription [2, 10].
ThetargetgenesofElongatordependalotonthebiologic
system studied. In yeast, loss of Elongator function reduced
the activation of a number of inducible genes [1, 2, 5]b u t
did not aﬀect transcription globally [2]. In plants, Elongator
contributesto the transcription of stress-induced and auxin-
relatedgenes[19,43].Inhumancells,Elongatorwasrequired
for the activation of several genes involved in migration [42]
and for the activation of HSP70 in heat shock conditions
[29]. Elongator was also involved in regulation of several
p53-dependent proapoptotic genes but in a manner that did
not seem to occur on the transcriptional level [44].
In line with a possible function for Elongator in regu-
lating these genes by facilitating their transcriptional elonga-
tion, several groups could now demonstrate that Elongator
preferentially occupies the open reading frames but not
the promoters of these genes [29, 42]. Indeed, Elongator
binding was mostly observed several kilobases downstream
ofthetranscriptional startsite(TSS)[45].Inyeast,Elongator
couldbe cross-linked to the nascent pre-mRNAsof regulated
genes [46]. In line with the initial puriﬁcation of Elongator
with the hyperphosphorylated form of RNAPII [1], time-
course experiments suggested that Elongator indeed arrives
at genes after hyperphosphorylation of RNAPII [47]. It has
to be pointed out that Elongator could also be found on
genes whose transcription was not aﬀected by its depletion
suggesting some functional redundancy of Elongator with
other elongation factors. Taking the function of Elongator
in the context of chromatin into account, it is the most
similartotheFACTcomplex.FACTwassuggestedtoregulate
Elongation by facilitating the procession of RNAPII through
nucleosomes [41]. In human cells, both FACT and Elongator
could be found on a common gene, where in contrast
to Elongator, FACT was bound at the more TSS-proximal
regions of the ORF [45]. This observation provokes the
intriguing speculation that FACT and Elongator could have
distinct functions in the early and late elongation process.
It is further interesting to note that genetic inactivation
of both FACT and Elongator resulted in synthetic lethality
in yeast [48]. Whether Elongator facilitates the opening
and reconstitution of nucleosomes in a FACT-like manner
remains to be investigated.
Taken together, a picture emerges in which Elongator
regulates the transcriptional elongation of a subset of
stress-inducible genes through acetylation of Histone H3
in the TSS distal gene body (see Figure 2). Although the
elongation function of Elongator is conserved, the subset of
regulated genes has diverged during evolution. Many open
questions remain such as how is the target gene speciﬁcity of
Elongator determined? What is the molecular consequence
of Elongator-mediated histone acetylation? Considering the
other functions of Elongator, manipulation of its function is
likely to aﬀect indirect as well as direct target genes. Hence,
it will inevitable to check for the presence of Elongator at
putative target genes when addressing the role of Elongator
in transcription.
4.Acetylationof Tubulin:Elongatorand
CellularMotility
The cytoskeleton is characterized by its dynamic structure
a n di sc o m p o s e do ft h r e et y p e so fﬁ b e r s :a c t i nﬁ l a m e n t s ,
intermediate ﬁlaments, and microtubules [49]. The func-
tions of the cytoskeleton go far beyond the maintenance of
cell shape and include important roles in cellular motility,
intracellular transport, and mitosis [50].
Microtubules are the biggest cytoskeletal ﬁbers that are
essentially composed of only two proteins, the α-a n dβ-
Tubulins [51]. Heterodimers of globular α-a n dβ-Tubulins
polymerize in a head-to-tail fashion to form the so-called4 Journal of Biomedicine and Biotechnology
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Figure 2: Two acetylation-dependent functions of Elongator. In the nucleus, Elongator-mediated acetylation of Histone H3 contributes to
transcriptional elongation. Thereby, it interacts with processive RNAPII, which is hyperphosphorylated at its C-terminal domain (CTD).
Although this function of Elongator is conserved from yeast to man, the subset of genes that underly this kind of regulation have diverged
during evolution. In the cytosol, Elongator acetylates the α-Tubulin subunit of microtubules. This acetylation event contributes to the
traﬃckingofcargo alongmicrotubules andcell migration.Pleasenotethat acetylationofα-Tubulin occurs in the lumen of microtubule, but
for reasons of illustration, it has been depicted on outside here.
protoﬁlaments. Of these protoﬁlaments, 13 bind to each
other in a parallel way to form the tubular structure of
the microtubule, which has a diameter of about 25nm.
An important characteristic of these microtubules is their
polarity.Theearlyinvitroobservationthatnewheterodimers
added faster to one end of the microtubules leads to the
distinction of plus and minus ends [52, 53]. Minus ends
terminate in α-Tubulin subunits and plus-ends accordingly
in β-Tubulin subunits. By establishing and maintaining cell
polarity, the remodelling of microtubules is particularly
important in directed cell migration processes [54, 55].
Several PTMs occur on Tubulins that are considered to
modulate the function of microtubulesby providing binding
sitesforregulatory proteins[56].These PTMs includetyrosi-
nation, polyglycylation, and polyglutamylation. Considering
the tubular architecture of microtubuli it is not surprising
that most PTMs occur on the carboxyterminal domains of
both α-a n dβ-Tubulins, which are exposed on the outer
surface of the tube [57].
Additionally, α-Tubulin but not β-Tubulin is acetylated
in vivo [58]. The particularity of this PTM is its localization.
The acetylation of α-Tubulin, which exclusively occurs
on lysine 40, is located on the luminal inner surface of
the microtubule [59]. While HDAC6 and Sirt2 have been
described a few years ago as tubulin deacetylases [60–62],
the responsible acetylase remained elusive. Just recently, the
Elp3 subunit of cytosolic Elongator was identiﬁed as α-
Tubulin-speciﬁc KAT in human and mouse cells [14]. It
could be shown by mutating a critical residue in the catalytic
domainofElp3thatElongatorisresponsible fora substantial
amount of tubulin acetylation [14]. Importantly, acetylation
of tubulin by Elongator does also occur in the nematode C.
elegans [63] suggesting a similar high degree of conservation
for the cytosolic function of Elongator as previously shown
for its nuclear role in transcription. The identiﬁcation of
MEC-17 as a second α-Tubulin acetyltransferase made clear
that Elongator is not the only one [64]. Indeed, in Tetrahy-
mena and neurons from zebraﬁsh embryos and C. elegans
hermaphrodites, MEC-17 was shown to berequired for most
if not all α-Tubulin acetylation. We can expect additional
acetyltransferases to be identiﬁed in the future, and the
task before the scientiﬁc community will be to sort out the
context-dependent contributions of each of these enzymes.
Acetylation of microtubules seems not to be essential
for cell survival but plays a role in cell motility and in
motor-based traﬃcking [65, 66]. The role of acetylation
in cell motility was ﬁrst demonstrated by several studies
reporting that HDAC6 overexpression that promotes α-
TubulindeacetylationincreasescellmotilitywhereasHDAC6
inhibitiontriggerstheoppositeeﬀect[60,67].Themigration
defects observed in neurons depleted for Elongator subunits
conﬁrmed the important function of tubulin acetylation
during motility processes [14, 63]. Similarly, the loss of the
otheracetyltransferase MEC-17reducedthetouchsensitivity
of neurons in C. elegans and induced phenotypes consistent
with neuromuscular defects in zebraﬁsh embryos [64].
However, what is the molecular mechanism by which
acetylation of tubulin aﬀects cellular motility? Some clues
came from studies of motor proteins that transport diverse
cargoes along microtubules. Microtubule-speciﬁc motorJournal of Biomedicine and Biotechnology 5
proteins are divided into two classes called dyneins and
kinesins depending on the direction of their movement
[68, 69]. Most of the members of the kinesin superfamily
move to the plus end of microtubules, whereas members of
the dynein superfamily transport their cargoes to the minus
end [70, 71].
Acetylation of α-Tubulin was shown to promote in
particular the binding and the motility of kinesin-1 [66].
In the cerebral cortex, Elongator mediated the acetylation of
microtubulesand couldtherebydirect anterograde transport
ofdeﬁnedcargoestogrowing neuritesindevelopingneurons
and to axons in mature cells [18]. Acetylation of α-
Tubulin was also associated recently to the posttranslational
ﬁne tuning of α-Tubulin levels and to the dynamics of
polymerization and depolymerization [63]. Both transport
and changes in the microtubule dynamics could directly
inﬂuence the cellular motility.
With the identiﬁcation of α-Tubulin as cytosolic target
f o rt h eE l o n g a t o r ’ sK A Ta c t i v i t y ,an e wc h a p t e rw a so p e n e d .
Many questions persist. For instance, it is not clear how
E l o n g a t o ro rt h ec o u n t e r a c t ing deacetylases HDAC6 and
SirtT2canaccess lysine40at its luminalposition. Itis further
still enigmatic how a luminal modiﬁcation can inﬂuence
the motor protein functions that occur on the cytoplasmic
surface of the microtubule. How are the activities of a-
Tubulin-speciﬁcacetylasesregulated?Itisinterestingtopoint
outthatthelevelofα-Tubulin acetylationisquitevariable.In
neurons,forinstance,thelargemajorityofcellularα-Tubulin
is acetylated.
5.DefectsinElongatorand
NeurodegenerativeDisorders
Elongator is associated to diﬀerent neuronal diseases. While
the familial dysautonomia is associated to mutation of the
IKBKAP gene encoding Elp1 [8, 72], the amyotrophic lateral
sclerosis was recently shown to be linked to allelic variants of
ELP3 [73].
Familial dysautonomia (FD), also known as Riley-Day
syndrome, is characterized by a progressive depletion of
unmyelinated sensory and autonomic neurons resulting in
a loss of neuronal function which leads to a complex
symptomatology including gastrointestinal dysfunction, lack
of overﬂow tears, absence of fungiform papillae on the
tongue and other autonomic disturbances [74]. The major
genetic cause of FD is a single noncoding mutation of the
Elp1 encoding gene which aﬀects its splicing. Interestingly,
this mutation is not fully penetrant, which means that
some residual amounts of the wild-type Elp1 (Elp1-WT)
mRNA are nevertheless synthesized. The central nervous
and the peripheral nervous systems are the major tissues
aﬀected by this splicing defect as demonstrated by the low
level of WT-Elp1 present in these tissues [75]. Amyotrophic
lateral sclerosis (ALS) is caused by the degeneration of
motor neurons resulting in muscle weakness and atrophy.
Aﬀectedpatientsshowcognitiveimpairmentsandusuallydie
from respiratory muscle weakness. Defects in Elongator have
already been implicated in the pathogenesis of ALS [73].
The observation that alterations of Elongator correlate
with two diﬀerent neurodegenerative disorders suggests that
Elongator has an essential function in the development and
the maintenance of neuronal networks. On the molecular
level, Elongator exerts its “neuronal” function at least
partially through acetylation of its two main substrates—
Histone H3 and α-Tubulin. On one hand, defective Elon-
gator could reduce the elongation of gene transcripts that
normally mediate the motility, the development, and the
survival of neuronal cells [42]. On the other hand, defects
in intracellular traﬃcking have already been linked to several
neurodegenerative diseases including Alzheimer’s disease,
Parkinson, disease, or ALS [76–78]. Thus, it is reasonable
to speculate that the loss of Elongator-mediated tubulin-
acetyation could result in defective intracellular transport
of cargo and thereby contribute to neurodegeneration, but
we have also to point out that Elongator might have
other yet unknown substrates that could contribute to the
symptomatology of FD and ALS.
6.Final Considerationsand Outlook
The two substrates of Elongator’s acetylase activity—α-
Tubulin and Histone H3—are as diﬀerent as the functions
of Elongator in the cytosol and the nucleus, or, do they have
anything in common? Well, both α-Tubulin and Histone H3
are main components of cellular macrocomplexes: micro-
tubules and chromatin. Both microtubules and chromatin
a r ef o r m e db yr e p e t i t i v eu n i t s .W ec a ns p e c u l a t et h a t
Elongator might act as a processive enzyme in which each
acetylation reaction would facilitate the next. This would
predict that Elongator has a preference for carrying out
sequential reactions. Experimentally, this could be tested in
acetylation assays by comparing single tubulin dimers and
microtubules. For both microtubules and chromatin it is
evident that Elongator is not the only acetylating enzyme. In
both cases acetylation has further been suggested to be one
of many modiﬁcations that together could form a type of
code. According to the histone or tubulin code hypotheses
[79, 80], the combination of modiﬁcations would be read
and interpret by factors that ultimately regulate the function
of chromatin and microtubules, respectively.
It was known that Elongator has also other acetylation-
independent functions in secretion and tRNA processing
[13]. Recent evidences further linked Elongator to the DNA-
damage response and gene silencing [32], RNA interference
[22],andglobalDNAdemethylation[30].Itlookslikealarge
number of cellular functions have evolved in parallel that
make use of the same highly conserved Elongator complex
albeit in very diﬀerent contexts. It remains to be seen which
functions of Elongator require its acetylase activity and what
would be the corresponding substrates. We are still far from
having a comprehensive view of all Elongator functions.
Acknowledgments
The authors thank Jesper Svejstrup, Laurent Nguyen, and
members from the Buschbeck lab for critically reading the6 Journal of Biomedicine and Biotechnology
manuscript. Research in the Buschbeck lab is supported by
a SAF2009 and a RYC2010 grant from the Spanish Ministry
of Science and Innovation. Catherine Creppe is supported
by a postdoctoral FEBS long-term fellowship and Marcus
Buschbeck holds a Ram´ on y Cajal position.
References
[1] G. Otero, J. Fellows, LI. Yang et al., “Elongator, a multisubunit
component of a novel RNA polymerase II holoenzyme for
transcriptional elongation,” Molecular Cell,v o l .3 ,n o .1 ,p p .
109–118, 1999.
[2] N. J. Krogan and J. F. Greenblatt, “Characterization of a six-
subunit Holo-Elongator complex required for the regulated
expression of a group of genes in Saccharomyces cerevisiae,”
Molecular and Cellular Biology, vol. 21, no. 23, pp. 8203–8212,
2001.
[3] Y. Li, Y. Takagi, Y. Jiang et al., “A Multiprotein Complex
That Interacts with RNA Polymerase II Elongator,” Journal of
Biological Chemistry, vol. 276, no. 32, pp. 29628–29631, 2001.
[4] G. Sebastiaan Winkler, T. G. Petrakis, S. Ethelberg et al.,
“RNA polymerase II elongator holoenzyme is composed of
two discrete subcomplexes,” Journal of Biological Chemistry,
vol. 276, no. 35, pp. 32743–32749, 2001.
[5] B. Ø. Wittschieben, G. Otero, T. De Bizemont et al., “A novel
histone acetyltransferase is an integral subunit of elongating
RNA polymerase II holoenzyme,” Molecular Cell,v o l .4 ,n o .1 ,
pp. 123–128, 1999.
[6] H. Nelissen, D. Fleury, L. Bruno et al., “The elongata mutants
identify a functional Elongator complex in plants with a role
in cell proliferation during organ growth,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 102, no. 21, pp. 7754–7759, 2005.
[ 7 ]Y .T .C h e n ,M .M .H i m s ,R .S .S h e t t ye ta l . ,“ L o s so f
mouse ikbkap, a subunit of elongator, leads to transcriptional
deﬁcits and embryonic lethality that can be rescued by human
IKBKAP,” Molecular and Cellular Biology,v o l .2 9 ,n o .3 ,p p .
736–744, 2009.
[8] S. A. Slaugenhaupt, A. Blumenfeld, S. P. Gill et al., “Tissue-
speciﬁc expression of a splicing mutation in the IKBKAP gene
causes familial dysautonomia,” American Journal of Human
Genetics,vol. 68, no. 3, pp. 598–605, 2001.
[ 9 ]N .A .H a w k e s ,G .O t e r o ,G .S e b a s t i a a nW i n k l e re ta l . ,
“Puriﬁcation and characterization of the human elongator
complex,” Journal of Biological Chemistry, vol. 277, no. 4, pp.
3047–3052, 2002.
[10] J. H. Kim, W. S. Lane, and D. Reinberg, “Human elongator
facilitates RNA polymerase II transcription through chro-
matin,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 99, no. 3, pp. 1241–1246, 2002.
[11] L. Fichtner, F. Frohloﬀ,D .J a b l o n o w s k i ,M .J .R .S t a r k ,a n d
R. Schaﬀrath, “Protein interactions within Saccharomyces
cerevisiae elongator, a complex essential for Kluyveromyces
lactis zymocicity,” Molecular Microbiology,v o l .4 5 ,n o .3 ,p p .
817–826, 2002.
[ 1 2 ]D .K .P o k h o l o k ,N .M .H a n n e t t ,a n dR .A .Y o u n g ,“ E x c h a n g e
ofRNA polymeraseII initiationandelongationfactors during
gene expression in vivo,” Molecular Cell, vol. 9, no. 4, pp. 799–
809, 2002.
[13] J. Q. Svejstrup, “Elongator complex: how many roles does it
play?” Current Opinion in Cell Biology, vol. 19, no. 3, pp. 331–
336, 2007.
[14] C. Creppe, L. Malinouskaya, M. L. Volvert et al., “Elongator
controls the migration and diﬀerentiation of cortical neurons
through acetylation of α-tubulin,” Cell, vol. 136, no. 3, pp.
551–564, 2009.
[15] A. Esberg, BO. Huang, M. J. O. Johansson, and A. S. Bystr¨ om,
“Elevated levels of two tRNA species bypass the requirement
forelongatorcomplexin transcriptionandexocytosis,” Molec-
ular Cell, vol. 24, no. 1, pp. 139–148, 2006.
[ 1 6 ]B O .H u a n g ,M .J .O .J o h a n s s o n ,a n dA .S .B y s t r ¨ om, “An
early step in wobble uridine tRNA modiﬁcation requires the
Elongator complex,” RNA, vol. 11, no. 4, pp. 424–436, 2005.
[17] P. B. Rahl, C. Z. Chen, and R. N. Collins, “Elp1p, the yeast
homologoftheFD diseasesyndromeprotein, negatively regu-
lates exocytosis independently of transcriptional elongation,”
Molecular Cell, vol. 17, no. 6, pp. 841–853, 2005.
[ 1 8 ] L .N g u y e n ,S .H u m b e r t ,F .S a u d o u ,a n dA .C h a r i o t ,
“Elongator—an emerging role in neurological disorders,”
Trends in Molecular Medicine, vol. 16, no. 1, pp. 1–6, 2010.
[ 1 9 ] Z .C h e n ,H .Z h a n g ,D .J a b l o n o w s k ie ta l . ,“ M u t a t i o n s
in ABO1/ELO2, a subunit of holo-elongator, increase
abscisic acid sensitivity and drought tolerance in Arabidopsis
thaliana,” Molecular and Cellular Biology, vol. 26, no. 18, pp.
6902–6912, 2006.
[ 2 0 ]F .L i ,J .L u ,Q .H a n ,G .Z h a n g ,a n dB .H u a n g ,“ T h eE l p 3
subunit of human Elongator complex is functionally similar
to its counterpart in yeast,” Molecular Genetics and Genomics,
vol. 273, no. 3, pp. 264–272, 2005.
[21] F. Frohloﬀ,D .J a b l o n o w s k i ,L .F i c h t n e r ,a n dR .S c h a ﬀrath,
“Subunit communications crucial for the functional integrity
of the yeast RNA polymerase II elongator (γ-toxin target
(TOT))complex,”J o u r n a lo fB i o l o gi c a lC h em i s try ,vol.278,no.
2, pp. 956–961, 2003.
[22] C. Lipardi and B. M. Paterson, “Identiﬁcation of an RNA-
dependent RNA polymerase in Drosophila involved in RNAi
and transposon suppression,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 106,
no. 37, pp. 15645–15650, 2009.
[23] J. Fellows, H. Erdjument-Bromage, P. Tempst, and J. Q.
Svejstrup,“TheElp2subunitofelongatorandelongatingRNA
polymerase II holoenzyme is a WD40 repeat protein,” Journal
of Biological Chemistry, vol. 275, no. 17, pp. 12896–12899,
2000.
[24] T. G. Petrakis, B. Ø. Wittschieben, and J. Q. Svejstrup,
“Molecular architecture, structure-function relationship, and
importance of the Elp3 subunit for the RNA binding of holo-
Elongator,”J ourna lo fBiol ogica lChemistry,vol.279,no.31,pp.
32087–32092, 2004.
[25] B. Ø. Wittschieben, J. Fellows, DU. Wendy, D. J. Stillman,
and J. Q. Svejstrup, “Overlapping roles for the histone
acetyltransferase activities of SAGA and Elongator in vivo,”
EMBO Journal, vol. 19, no. 12, pp. 3060–3068, 2000.
[26] C. Paraskevopoulou, S. A. Fairhurst, D. J. Lowe, P. Brick, and
S. Onesti, “The Elongator subunit Elp3 contains a FeS cluster
and binds S-adenosylmethionine,” Molecular Microbiology,
vol. 59, no. 3, pp. 795–806, 2006.
[ 2 7 ]C .G r e e n w o o d ,L .A .S e l t h ,A .B a r b a r aD i r a c - S v e j s t r u p ,a n d
J. Q. Svejstrup, “An iron-sulfur cluster domain in Elp3
important for the structural integrity of elongator,” Journal of
Biological Chemistry, vol. 284, no. 1, pp. 141–149, 2009.
[28] Y. Chinenov, “A second catalytic domain in the Elp3 histone
acetyltransferases: a candidate for histone demethylase activ-
ity?”TrendsinBiochemicalSciences,vol.27,no.3,pp.115–117,
2002.Journal of Biomedicine and Biotechnology 7
[29] Q. Han, X. Hou, D. Su et al., “HELP3 subunit of the Elongator
complex regulates the transcription of HSP70 gene in human
cells,” Acta Biochimica et Biophysica Sinica,v o l .3 9 ,n o .6 ,p p .
453–461, 2007.
[30] Y.Okada,K.Yamagata,K.Hong,T.Wakayama,andYI.Zhang,
“A role for the elongator complex in zygotic paternal genome
demethylation,” Nature, vol.463, no.7280, pp. 554–558,2010.
[31] C. P. Ponting, “Novel domains and orthologues of eukaryotic
transcription elongation factors,” Nucleic Acids Research,v o l .
30, no. 17, pp. 3643–3652, 2002.
[32] Q. Li, A. M. Fazly, H. Zhou, S. Huang, Z. Zhang, and B.
Stillman, “The elongator complex interacts with PCNA and
modulates transcriptional silencing and sensitivity to DNA
damage agents,” PLoS Genetics, vol. 5, no. 10, Article ID
e1000684, 2009.
[33] F. Frohloﬀ,L .F i c h t n e r ,D .J a b l o n o w s k i ,K .D .B r e u n i g ,a n d
R. Schaﬀrath, “Saccharomyces cerevisiae Elongator mutations
conferresistancetotheKluyveromyces lactiszymocin,”EMBO
Journal, vol. 20, no. 8, pp. 1993–2003, 2001.
[34] G. S. Winkler, A. Kristjuhan, H. Erdjument-Bromage, P.
Tempst, and J. Q. Svejstrup, “Elongator is a histone H3 and
H4 acetyltransferaseimportant fornormalhistoneacetylation
levels in vivo,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 99, no. 6, pp. 3517–3522,
2002.
[35] L. Cohen, W. J. Henzel, and P. A. Baeuerle, “IKAP is a scaﬀold
protein of the IκBk i n a s ec o m p l e x , ”Nature, vol. 395, no. 6699,
pp. 292–296, 1998.
[36] R. G. Collum, S. Brutsaert, G. Lee, and C. Schindler, “A
Stat3-interacting protein (StIP1) regulates cytokine signal
transduction,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 97, no. 18, pp. 10120–
10125, 2000.
[ 3 7 ]D .J a b l o n o w s k i ,L .F i c h t n e r ,M .J .R .S t a r k ,a n dR .S c h a ﬀrath,
“Theyeastelongatorhistoneacetylaserequires Sit4-dependent
dephosphorylation for toxin-target capacity,” Molecular Biol-
ogy of the Cell, vol. 15, no. 3, pp. 1459–1469, 2004.
[38] C. Mehlgarten, D. Jablonowski, K. D. Breunig, M. J. R.
Stark, and R. Schaﬀrath, “Elongator function depends on
antagonistic regulation by casein kinase Hrr25 and protein
phosphatase Sit4,” Molecular Microbiology,v o l .7 3 ,n o .5 ,p p .
869–881, 2009.
[ 3 9 ]G .W .M u s e ,D .A .G i l c h r i s t ,S .N e c h a e ve ta l . ,“ R N A
polymeraseispoisedforactivationacrossthegenome,”Nature
Genetics,vol. 39, no. 12, pp. 1507–1511, 2007.
[40] J. Zeitlinger, A. Stark, M. Kellis et al., “RNA polymerase
stalling at developmental control genes in the Drosophila
melanogaster embryo,” Nature Genetics, vol. 39, no. 12, pp.
1512–1516, 2007.
[41] R. J. Sims, R. Belotserkovskaya, and D. Reinberg, “Elongation
by RNA polymerase II: the short and long of it,” Genes and
Development, vol. 18, no. 20, pp. 2437–2468, 2004.
[42] P. Close, N. Hawkes, I. Cornez et al., “Transcription impair-
ment and cell migration defects in elongator-depleted cells:
implicationforfamilialdysautonomia,”MolecularCell,vol.22,
no. 4, pp. 521–531, 2006.
[43] H. Nelissen, S. De Groeve, D. Fleury et al., “Plant Elongator
regulates auxin-related genes during RNA polymerase II
transcriptionelongation,”Proceedings ofthe National Academy
of Sciences of the United States of America, vol. 107, no. 4, pp.
1678–1683, 2010.
[44] I. Cornez, C. Creppe, M. Gillard et al., “Deregulated expres-
sion of pro-survival and pro-apoptotic p53-dependent genes
upon Elongator deﬁciency in colon cancer cells,” Biochemical
Pharmacology, vol. 75, no. 11, pp. 2122–2134, 2008.
[45] A. Kouskouti and I. Talianidis, “Histone modiﬁcations deﬁn-
ing active genes persist after transcriptional and mitotic in
activation,” EMBO Journal, vol. 24, no. 2, pp. 347–357, 2005.
[46] C. Gilbert, A. Kristjuhan, G. S. Winkler, and J. Q. Svejstrup,
“Elongator interactions with nascent mRNA revealed by RNA
immunoprecipitation,” Molecular Cell, vol. 14, no. 4, pp. 457–
464, 2004.
[47] R. M´ etivier, G. Penot, M. R. H¨ ubner et al.,“Estrogen receptor-
α directs ordered, cyclical, and combinatorial recruitment of
cofactors on a natural target promoter,” Cell, vol. 115, no. 6,
pp. 751–763, 2003.
[48] T.Formosa,S.Ruone,M.D.Adamsetal.,“Defects inSPT16or
POB3(yFACT) inSaccharomycescerevisiae cause dependence
on the Hir/Hpc pathway: polymerase passage may degrade
chromatin structure,” Genetics,vol. 162, no. 4, pp. 1557–1571,
2002.
[49] S. Etienne-Manneville, “Actin and microtubules in cell motil-
ity: which oneis in control?” Traﬃc, vol.5, no. 7, pp. 470–477,
2004.
[50] G. Liao, T. Nagasaki, and G. G. Gundersen, “Low concen-
trations of nocodazole interfere with ﬁbroblast locomotion
without signiﬁcantly aﬀecting microtubule level: implications
for the role of dynamic microtubules in cell locomotion,”
Journal of Cell Science, vol. 108, no. 11, pp. 3473–3483, 1995.
[51] K. H. Downing and E. Nogales, “Tubulin structure: insights
into microtubule properties and functions,” Current Opinion
in Structural Biology, vol. 8, no. 6, pp. 785–791, 1998.
[52] T. Horio and H. Hotani, “Visualization of the dynamic insta-
bility of individual microtubules by dark-ﬁeld microscopy,”
Nature, vol. 321, no. 6070, pp. 605–607, 1986.
[53] T. Mitchinson and M. Kirschner, “Dynamic instability of
microtubule growth,” Nature, vol. 312, no. 5991, pp. 237–242,
1984.
[54] J. V. Small and I. Kaverina, “Microtubules meet substrate
adhesions to arrange cell polarity,” Current Opinion in Cell
Biology, vol. 15, no. 1, pp. 40–47, 2003.
[55] M. Vicente-Manzanares, D. J. Webb, and A. R. Horwitz, “Cell
migration at a glance,” Journal of Cell Science, vol. 118, no. 21,
pp. 4917–4919, 2005.
[56] K. J. Verhey and J. Gaertig, “The tubulin code,” Cell Cycle,v o l .
6, no. 17, pp. 2152–2160, 2007.
[57] K. H. Downing and E. Nogales, “Tubulin and microtubule
structure,” Current Opinion in Cell Biology, vol. 10, no. 1, pp.
16–22, 1998.
[58] S. W. L’Hernault and J. L. Rosenbaum, “Chlamydomonas α-
tubulin is posttranslationally modiﬁed by acetylation on the
ε-amino group of a lysine,” Biochemistry,v o l .2 4 ,n o .2 ,p p .
473–478, 1985.
[59] M. LeDizet and G. Piperno, “Identiﬁcation of an acetylation
site of Chlamydomonas alpha-tubulin,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 84, no. 16, pp. 5720–5724, 1987.
[60] C. Hubbert, A. Guardiola, R. Shao et al., “HDAC6 is a
microtubule-associated deacetylase,” Nature, vol. 417, no.
6887, pp. 455–458, 2002.
[61] Y. Zhang, N. Li, C. Caron et al., “HDAC-6 interacts with and
deacetylates tubulin and microtubules in vivo,” The EMBO
Journal, vol. 22, no. 5, pp. 1168–1179, 2003.
[62] B. J. North, B. L. Marshall, M. T. Borra, J. M. Denu, and
E. Verdin, “The human Sir2 ortholog, SIRT2, is an NAD+-
dependent tubulin deacetylase,” Molecular Cell, vol. 11, no. 2,
pp. 437–444, 2003.8 Journal of Biomedicine and Biotechnology
[63] J. A. Solinger, R. Paolinelli, H. Kl¨ oß et al., “The Caenorhab-
ditis elegans elongator complex regulates neuronal α-tubulin
acetylation,” PLoS Genetics, vol. 6, no. 1, Article ID e1000820,
2010.
[64] J. S. Akella, D. Wloga, J. Kim et al., “MEC-17 is an α-tubulin
acetyltransferase,” Nature, vol. 467, no. 7312, pp. 218–222,
2010.
[65] J. P. Dompierre, J. D. Godin, B. C. Charrin et al., “Histone
deacetylase 6 inhibition compensates for the transport deﬁcit
in Huntington’s disease by increasing tubulin acetylation,”
Journal of Neuroscience, vol. 27, no. 13, pp. 3571–3583, 2007.
[66] N.A.Reed, D.Cai,T.L.Blasiusetal.,“Microtubuleacetylation
promotes kinesin-1 binding and transport,” Current Biology,
vol. 16, no. 21, pp. 2166–2172, 2006.
[67] S. J. Haggarty, K. M. Koeller, J.C. Wong,C. M. Grozinger, and
S.L. Schreiber, “Domain-selective small-moleculeinhibitor of
histone deacetylase 6 (HDAC6)-mediated tubulin deacetyla-
tion,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 100, no. 8, pp. 4389–4394, 2003.
[68] S. A. Endow, “Microtubule motors in spindle and chromo-
some motility,” European Journal of Biochemistry, vol. 262, no.
1, pp. 12–18, 1999.
[69] E. P. Sablin, R. B. Case, S. C. Dai et al., “Direction determi-
nation in the minus-end-directed kinesin motorncd,” Nature,
vol. 395, no. 6704, pp. 813–816, 1998.
[70] R. Mallik and S. P. Gross, “Molecular motors: strategies to get
along,” Current Biology, vol. 14, no. 22, pp. R971–R982, 2004.
[71] M. Schliwa and G. Woehlke, “Molecular motors,” Nature,v o l .
422, no. 6933, pp. 759–765, 2003.
[72] S. L. Anderson, R. Coli, I. W. Daly et al., “Familial dysau-
tonomia is caused by mutations of the IKAP gene,” American
Journal of Human Genetics,vol. 68, no. 3, pp. 753–758, 2001.
[73] C. L. Simpson, R. Lemmens, K. Miskiewicz et al., “Variants of
the elongator protein 3 (ELP3)gene are associated withmotor
neuron degeneration,” Human Molecular Genetics,vol. 18, no.
3, pp. 472–481, 2009.
[74] F. B. Axelrod, “Familialdysautonomia,”Muscle and Nerve,v o l .
29, no. 3, pp. 352–363, 2004.
[75] M. P. Cuajungco, M. Leyne, J. Mull et al., “Tissue-speciﬁc
reduction in splicing eﬃciency of IKBKAP due to the major
mutation associated with familial dysautonomia,” American
Journal of Human Genetics,vol. 72, no. 3, pp. 749–758, 2003.
[76] K. J. De vos, A. L. Chapman, M. E. Tennant et al., “Familial
amyotrophic lateral sclerosis-linked SOD1 mutants perturb
fast axonaltransport to reduce axonal mitochondria content,”
Human Molecular Genetics, vol. 16, no. 22, pp. 2720–2728,
2007.
[77] A. R. Saha, J. Hill, M. A. Utton et al., “Parkinson’s disease
α-synuclein mutations exhibit defective axonal transport in
cultured neurons,” J o u r n a lo fC e l lS c i e n c e , vol. 117, no. 7, pp.
1017–1024, 2004.
[78] G. B. Stokin, C. Lillo, T. L. Falzone et al., “Axonopathy and
transport deﬁcits early in the pathogenesis of Alzheimer’s
diseases,” Science, vol. 307, no. 5713, pp. 1282–1288, 2005.
[79] J. W. Hammond, D. Cai, and K. J. Verhey, “Tubulin modiﬁ-
cations and their cellular functions,” Current Opinion in Cell
Biology, vol. 20, no. 1, pp. 71–76, 2008.
[80] B. D. Strahl and C. D. Allis, “The language of covalent histone
modiﬁcations,” Nature, vol. 403, no. 6765, pp. 41–45, 2000.